Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary and luminal proteins and peptides in the intestinal lumen represent a diverse group of macromolecules derived from food intake and endogenous secretions. These substances are essential for providing amino acids required for protein synthesis and metabolic processes throughout the body (Source: StatPearls). In the intestinal lumen, they undergo mechanical and chemical digestion, primarily through the action of gastric and pancreatic proteases such as pepsin, trypsin, and chymotrypsin (Source: NIH). Beyond their nutritional role, certain dietary proteins can act as triggers for immune-mediated diseases, most notably gluten in Celiac disease (Source: Mayo Clinic). They also serve as precursors to bioactive peptides that can influence satiety, glucose metabolism, and gut motility (Source: PubMed). Therapeutic strategies targeting this group often focus on enhancing their breakdown in patients with digestive enzyme deficiencies, such as exocrine pancreatic insufficiency (Source: StatPearls). Other interventions involve neutralizing specific immunogenic peptides to prevent inflammatory cascades in sensitive individuals. Additionally, the presence of these proteins can affect the pharmacokinetics of co-administered drugs, particularly those that are peptide-based.
The primary mechanism of action involves the enzymatic hydrolysis of peptide bonds, which reduces complex proteins into smaller peptides and amino acids to facilitate absorption or eliminate immunogenic epitopes (Source: StatPearls). In some cases, pharmacological agents may act by sequestering these proteins or inhibiting the transporters responsible for their uptake (Source: PubMed).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary and luminal proteins and peptides.